Us Bancorp \De\ Codexis, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Codexis, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 160 shares of CDXS stock, worth $702. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 160 -0.0%

Holding current value

$702

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$2.21 - $4.43 $280 - $562	-127 Reduced 44.25%	160 $0
Q1 2023 May 09, 2023	SELL	$3.81 - $6.76 $43,083 - $76,442	-11,308 Reduced 97.52%	287 $1,000
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $12,741 - $20,458	-2,991 Reduced 20.51%	11,595 $54,000
Q3 2022 Oct 27, 2022	BUY	$6.06 - $12.86 $15,392 - $32,664	2,540 Added 21.09%	14,586 $89,000
Q2 2022 Aug 01, 2022	BUY	$8.35 - $21.89 $30,611 - $80,248	3,666 Added 43.75%	12,046 $126,000
Q1 2022 May 11, 2022	BUY	$16.97 - $31.93 $119,180 - $224,244	7,023 Added 517.54%	8,380 $172,000
Q4 2021 Feb 11, 2022	BUY	$25.61 - $41.78 $179 - $292	7 Added 0.52%	1,357 $42,000
Q3 2021 Nov 10, 2021	BUY	$19.65 - $27.99 $6,563 - $9,348	334 Added 32.87%	1,350 $31,000
Q2 2021 Aug 05, 2021	BUY	$17.48 - $25.46 $8,425 - $12,271	482 Added 90.26%	1,016 $23,000
Q1 2021 Apr 28, 2021	BUY	$18.08 - $28.8 $1,247 - $1,987	69 Added 14.84%	534 $12,000
Q2 2020 Aug 07, 2020	BUY	$9.8 - $12.77 $4,557 - $5,938	465 New	465 $5,000
Q1 2020 May 13, 2020	SELL	$8.78 - $18.6 $8,780 - $18,600	-1,000 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$15.53 - $22.15 $15,530 - $22,150	1,000 New	1,000 $21,000

Others Institutions Holding CDXS

# of Institutions

143

Shares Held

60.6M

Call Options Held

68.5K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $288M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account